Medine.co.uk

Meloxicam 15 Mg Tablets

PAGE 4: AFTER FOLDING REAR FACE (OUTSIDE OF REEL AFTER FOLDING AND TACKING)

FOLD

LINE. PAGE 1: AFTER FOLDING FRONT FACE (INSIDE OF REEL AFTER FOLDING AND TACKING)

•    feeling your heartbeat (palpitations)

•    ulcers of the stomach or upper part of the small bowels (peptic/gastroduodenal ulcers)

•    inflammation of the gullet (oesophagitis)

•    onset of asthma attacks (seen in people who are allergic to aspirin or other NSAIDs)

•    potentially life-threatening skin rashes (Stevens-Johnson Syndrome and toxic epidermal necrolysis) have been reported (see section 2)

•    nettle rash (urticaria)

•    visual disturbances including:

•    blurred vision

•    conjunctivitis (inflammation of the eyeball or eyelids)

•    Inflammation of the large bowel (colitis).

Very rare (may affect up to 1 in 10,000 people):

•    blistering reactions of the skin (bullous reactions) and erythema multiforme. Erythema multiforme is a serious allergic skin reaction causing spots, red welts or purple or blistered areas. It can also affect the mouth, eyes and other moist body surfaces

•    inflammation of the liver (hepatitis). This can cause symptoms such as:

•    yellowing of the skin or the eyeballs (jaundice)

•    pain in the abdomen

•    loss of appetite

•    acute failure of the kidneys (renal failure) in particular in patients with risk factors such as disease, diabetes or kidney disease

•    a hole in the wall of the bowels (perforation).

Not known (frequency cannot be estimated from the available data)

•    confusion

•    disorientation

•    shortness of breath and skin reactions (anaphylactic/anaphylactoid reactions) rashes caused by exposure to sunlight (photosensitivity reactions)

•    heart failure (cardiac failure) has been reported in association with NSAID treatment

•    complete loss of specific types of white blood cells (agranulocytosis), especially in patients who take meloxicam together with other drugs that are potentially inhibitory, depressant or destructive to a component of the bone marrow (myelotoxic drugs). This can cause:

•    sudden fever

•    sore throats

•    infections.

Side effects caused by non-steroidal anti-inflammatory medicines (NSAIDs), but not yet seen after taking meloxicam

•    changes to the kidney structure resulting in acute kidney failure

•    very rare cases of kidney inflammation (interstitial nephritis)

•    death of some of the cells within the kidney (acute tubular or papillary necrosis)

•    protein in the urine (nephrotic syndrome with proteinuria)

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard By reporting side effects you can help provide more information on the safety of this medicine


HOW TO STORE MELOXICAM

Keep this medicine out of the sight and reach of children.

Do not use Meloxicam after the expiry date which is stated on the carton. The expiry date refers to the last day of that month.

This medicinal product does not require any special storage conditions.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

©CONTENTS OF THE PACK AND OTHER INFORMATION

What Meloxicam contains

The active substance is meloxicam. Each tablet contains 7.5 mg or 15 mg meloxicam. The other ingredients are sodium citrate, lactose monohydrate, microcrystalline cellulose, povidone K-30, colloidal anhydrous silica, crospovidone and magnesium stearate.

What Meloxicam looks like and contents of the pack

Meloxicam 7.5 mg tablets are yellow mottled, round, flat bevel-edged tablets debossed with "MLX" over "7.5" on one side and scored on the other side. Meloxicam 15 mg tablets are yellow mottled, oval, debossed with "MLX" over "15" on one side and scored on the other side.

The scoreline is only to help break the tablet for ease of swallowing and not to divide it into equal doses.

The product is available in pack sizes of 10, 14, 20, 28, 30, 50, 60, 100 or 500 (10 x 50) tablets

Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer:

TEVA UK Ltd,

Brampton Road, Hampden Park,

Eastbourne, East Sussex, BN22 9AG, England.

This leaflet was last revised in May 2015

PL 00289/0870- 0871


ttwti    85115-ZA

TEVA UK LIMITED    320 x 323


MELOXICAM 7.5 mg TABLETS MELOXICAM 15 mg TABLETS

Meloxicam

PACKAGE LEAFLET: INFORMATION FORTHE USER

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

•    Keep this leaflet. You may need to read it again.

•    If you have any further questions, ask your doctor or pharmacist.

•    This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

•    If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

WHAT IS IN THIS LEAFLET:

1.    What Meloxicam is and what it is used for

2.    What you need to know before you take Meloxicam

__ 3. How to take Meloxicam

4.    Possible side effects

5.    How to store Meloxicam

6.    Contents of the pack and other information

OWHAT MELOXICAM IS AND WHAT IT IS USED FOR

Meloxicam belongs to a group of drugs called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are used to reduce inflammation and pain in the joints and muscles.

Meloxicam is used for:

•    Short-term treatment of the symptoms of osteoarthritis (excessive wear on joints) when this condition flares up

•    Long-term treatment of the symptoms of rheumatoid arthritis

•    Long-term treatment of the symptoms of ankylosing spondylitis (inflammation of the joints between the spine and pelvis).

WHAT YOU NEED TO KNOW BEFORE YOU TAKE MELOXICAM

Do not take Meloxicam

Do not take meloxicam in the following circumstances:

•    allergy (hypersensitivity) to meloxicam or to any of the other ingredients of this medicine (listed in section 6)

•    allergy (hypersensitivity) to aspirin or other anti-inflammatory medicines (NSAIDs)

•    any of the following signs after taking aspirin or other NSAIDs:

•    wheezing, chest tightness, breathlessness (asthma)

•    nasal blockage due to swellings in the lining in your nose (nasal polyps)

•    skin rashes/nettle rash (urticaria)

•    sudden skin or mucosal swelling, such as swelling around the eyes, face, lips, mouth or throat, possibly making breathing difficult (angioneurotic oedema)

•    after previous therapy with NSAIDs and a history of:

•    bleeding in your stomach or intestines

•    holes (perforations) in your stomach or intestines

•    ulcers or bleeding in your stomach or intestines

•    recent or history of stomach or intestinal ulcers or bleeding (ulceration or bleeding occurring at least twice)

•    severely impaired liver function

•    non-dialysed severe kidney failure

•    recent bleeding in the brain (cerebrovascular bleeding)

•    any kind of bleeding disorders

•    severe heart failure

•    during the last three months of pregnancy

•    if you are breast-feeding

•    children and adolescents under 16 years of age.

Warnings and precautions

Medicines such as Meloxicam may be associated with a small increased risk of heart attack ("myocardial infarction") or stroke. Any risk is more likely with high doses and prolonged treatment. Do not exceed the recommended dose. Do not take Meloxicam for longer than it is prescribed for you (see section 3 "How to take Meloxicam").

If you have heart problems, previous stroke or think that you might be at risk of these conditions, you should discuss your treatment with your doctor or pharmacist. For example if you:

•    have high blood pressure (hypertension)

•    have high levels of sugar in the blood (diabetes mellitus)

•    have high levels of cholesterol in the blood (hypercholesterolemia)

•    are a smoker.

Meloxicam is not appropriate if you require immediate relief from acute pain.

NSAIDs including meloxicam may mask the symptoms (e.g. fever) of an underlying infection. If you develop signs of infection, or if the symptoms worsen, you should contact your doctor.

If you are a woman, meloxicam may make it more difficult to conceive. Tell your doctor if you are planning to become pregnant or are having problems conceiving. You should not take meloxicam if you are undergoing fertility treatment.

Potentially life-threatening skin rashes (Stevens-Johnson syndrome, toxic epidermal necrolysis) have been reported with the use of meloxicam, appearing initially as reddish target-like spots or circular patches often with central blisters on the trunk. Additional signs to look for include ulcers in the mouth, throat, nose, genitals and conjunctivitis (red and swollen eyes). These potentially life-threatening skin rashes are often accompanied by flu-like symptoms. The rash may progress to widespread blistering or peeling of the skin. The highest risk for occurrence of serious skin reactions is within the first month of treatment. If you have developed Stevens-Johnson syndrome or toxic epidermal necrolysis with the use of meloxicam, you must not be re-started on meloxicam at any time. If you develop a rash or these skin symptoms, stop taking meloxicam, seek urgent advice from a doctor and tell him that you are taking this medicine.

Your doctor may want to monitor your liver and kidneys during your treatment with meloxicam, in order to make sure they are working properly.

As it will be necessary to adjust the treatment, it is important to ask for your doctor's advice before you take meloxicam in the following cases:

•    history of inflammation of the gullet (oesophagitis), inflammation of the stomach (gastritis) or any other disease of the digestive tract, e.g. ulcerative colitis, Crohn's disease

Peel Here To Open

Nl

Pharma code 558 (1000101111)

Top of page cut-off to middle of registration mark = 44 mm    First bar is 105mm from top edge


FOLD

LINE.


PAGE 2: LEFT HAND INSIDE FACE AFTER FOLDING AND TACKING

PAGE 3: RIGHT HAND INSIDE FACE AFTER FOLDING AND TACKING

•    high blood pressure (hypertension)

•    older age

•    heart, liver or kidney disease

•    high levels of sugar in the blood (diabetes mellitus)

•    reduced blood volume (hypovolaemia) which may occur if you have a serious blood loss or burn, surgery or low fluid intake

•    high potassium levels in the blood previously diagnosed by your doctor.

Your doctor may monitor your progress whilst on treatment.

Higher doses than recommended can entail serious risks. Therefore, do not exceed the recommended daily dose, and do not use other anti-inflammatory medicines (NSAIDs) at the same time. This is especially important if you are elderly, as the risk of side effects is higher.

Other medicines and Meloxicam

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

In particular, please tell your doctor or pharmacist if you are taking/have taken any of the following:

•    other NSAIDs

•    medicines which prevent the blood clotting

•    medicines which break down blood clots (thrombolytics)

•    medicines to treat heart and kidney disease

•    corticosteroids

•    ciclosporin - used after organ transplants, or for severe skin conditions, rheumatoid arthritis or nephrotic syndrome

•    any diuretic medicine ("water tablets"). Your doctor may want to monitor your kidney function if you are taking diurectics

•    lithium - used to treat mood disorders

•    selective Serotonin re-uptake inhibitors -used in the treatment of depression

•    methotrexate - used to treat tumours or severe uncontrolled skin conditions and active rheumatoid arthritis

•    cholestyramine - mainly used to lower cholesterol levels

•    if you are a woman who uses an intrauterine contraceptive device (IUD), usually known as a coil.

Taking other anti-inflammatory medicines or medicines which prevent or break down blood clots at the same time as meloxicam may increase the risk of stomach or intestinal ulcers, bleeding and damage to the gut and stomach lining. The use of these medicines at the same time as meloxicam is therefore not recommended.

Pregnancy and breast-feeding

If pregnancy is established during use of meloxicam, then the doctor is to be notified.

During the first 6 months of pregnancy your doctor may punctually prescribe you this medical product if necessary.

During the last three months of pregnancy, do not use this product because meloxicam can have serious effects on your child, in particular cardiopulmonary and renal effects, even with only one administration.

This product may not be used during breast-feeding.

If you are pregnant or breast-feeding, think you may be pregnant or planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machines

Meloxicam may slightly affect your ability to

drive and handle machines, due to the


possibility of dizziness, drowsiness and blurred vision as side effects of treatment. If you experience such effects, do not drive or use machines until the symptoms wear off. Ask your doctor or pharmacist for advice.

Meloxicam contains lactose

Meloxicam tablets contain lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.

^ HOW TO TAKE MELOXICAM

Your doctor has decided the dose which is suited to you. Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is described below.

This medicinal product is for oral use only. You must swallow your full daily dose as a single dose with water or another liquid during a meal.

The recommended dose is as follows:

Flare-ups of osteoarthritis:

One 7.5 mg tablet a day, which may be increased after consultation with your doctor to 15 mg a day (two 7.5 mg tablets or one 15 mg tablet).

Rheumatoid arthritis:

One 15 mg tablet per day (or two 7.5 mg tablets). This may be reduced to one 7.5 mg tablet once a day.

Ankylosing spondylitis:

One 15 mg tablet per day (or two 7.5 mg tablets). This may be reduced to one 7.5 mg tablet once a day.

Do not exceed the dose of 15 mg a day.

Meloxicam must not be given to children and adolescents under 16 years of age.

Please contact your doctor or pharmacist if you are not sure how to take this medicine or if you feel that the effect of meloxicam is too strong or too weak.

Please note that this product is available in other strengths and pharmaceutical forms which may be more suitable for your treatment.

Information for elderly patients and for patients with impaired kidney or liver function

For elderly patients, the recommended dose for long-term treatment of rheumatoid arthritis or ankylosing spondylitis is 7.5 mg per day. Also, patients at high risk of side effects should start treatment with 7.5 mg a day.

If you have severe kidney dysfunction and receive dialysis, the maximum dose of meloxicam should be 7.5 mg per day.

If you take more Meloxicam than you should

Symptoms of overdose are usually limited to lethargy, drowsiness, nausea, vomiting and pain in the stomach. These symptoms are generally reversible. Severe overdose, however, may result in serious adverse drug reactions (see section 4, below). Seek medical advice immediately if the prescribed dose has been exceeded.

If you forget to take Meloxicam

Do not take a double dose to make up for a forgotten dose.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


^ POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Stop taking Meloxicam and consult a doctor or your nearest hospital immediately if you notice:

Any allergic (hypersensitivity) reactions, which may appear in the form of:

•    skin reactions, such as itching (pruritus), blistering or peeling of the skin, which can be severe (Steven-Johnson Syndrome and toxic epidermal necrolysis), lesions of soft tissues (mucosal lesions) or erythema multiforme.

Erythema multiforme is a serious allergic reaction causing spots, red welts or purple or blistered areas. It can also affect the mouth, eyes and other moist body surfaces

•    swelling of skin or mucosa, such as swelling around the eyes, face and lips, mouth or throat, possibly making breathing difficult, swollen ankles or legs (oedema of the lower limbs)

•    shortness of breath or asthma attack

•    inflammation of the liver (hepatitis). This can cause symptoms such as:

•    yellowing of the skin or the eyeballs (jaundice)

•    pain in the abdomen

•    loss of appetite.

Any side effects of the digestive tract, especially:

•    bleeding (causing tar-coloured stools)

•    ulceration of your digestive tract (causing abdominal pain).

Bleeding of the digestive tract (gastrointestinal bleeding), formation of ulcers or formation of a hole in the digestive tract (perforation) may sometimes be severe and potentially fatal, especially in elderly.

If you have previously suffered from any symptoms of the digestive tract due to long term use of NSAIDs, seek medical advice immediately, especially if you are elderly. Your doctor may monitor your progress whilst on treatment.

If affected by visual disturbances do not drive or operate machinery.

General side effects of non-steroidal anti-inflammatory medicines (NSAIDs)

The use of some non-steroidal anti-inflammatory drugs (NSAIDs) may be associated with a small increased risk of occlusion of arterial vessels (arterial thrombotic events), e.g. heart attack (myocardial infarction) or stroke (apoplexy), particularly at high doses and in long term treatment.

Fluid retention (oedema), high blood pressure (hypertension) and heart failure (cardiac failure) have been reported in association with NSAID treatment.

The most commonly-observed side effects affect the digestive tract (gastrointestinal events):

•    ulcers of the stomach and upper part of the small bowels (peptic/gastroduodenal ulcers)

•    a hole in the wall of the bowels (perforation) or bleeding of the digestive tract (sometimes fatal, particularly in the elderly).

The following side effects have been reported after NSAID administration:

•    feeling sick (nausea) and being sick (vomiting)

•    loose stools (diarrhoea)

•    flatulence

•    constipation

•    indigestion (dyspepsia)

•    abdominal pain

•    tar-coloured stool due to bleeding in the digestive tract (maleana)

•    vomiting of blood (haematemesis)

•    inflammation with building of ulcers in the mouth (ulcerative stomatitis)

•    worsening of inflammation of the large bowels (exacerbation of colitis)

•    worsening of inflammation of the digestive tract (exacerbation of Crohn's disease).

Less frequently, inflammation of the stomach (gastritis) has been observed.

Side effects of meloxicam

Very common (may affect more than 1 in 10 people):

•    indigestion (dyspepsia)

•    feeling sick (nausea) or being sick (vomiting)

•    abdominal pain

•    constipation

•    flatulence

•    loose stools (diarrhoea).

Common (may affect 1 to 10 in 100 people):

•    headache.

Uncommon (may affect up to 1 in 100 people):

•    dizziness (light-headedness)

•    a feeling of dizziness of spinning (vertigo)

•    somnolence (drowsiness)

•    anaemia (reduction of the concentration of the red blood pigment haemoglobin)

•    increase in blood pressure (hypertension)

•    flushing (temporary redness of the face and neck)

•    sodium and water retention

•    increased potassium levels (hyperkalaemia). This can lead to symptoms such as:

•    changes in your heartbeat (arrythmias)

•    palpitations (when you feel your heartbeat more than usual)

•    muscle weakness

•    eructation

•    inflammation of the stomach (gastritis)

•    bleeding of the digestive tract

•    inflammation of the mouth (stomatitis)

•    immediate allergic (hypersensitivity) reactions

•    itching (pruritus)

•    skin rash

•    swelling caused by fluid retention (oedema), including swollen ankles/legs (oedema of the lower limbs)

•    sudden skin or mucosal swelling, such as swelling around the eyes, face, lips, mouth or throat, possibly making breathing difficult (angioneurotic oedema)

•    momentary disturbance of liver function tests (e.g. raised liver enzymes like transaminases or an increase of the bile pigment bilirubin). Your doctor can detect these using a blood test

•    Disturbance of laboratory tests investigating kidney (renal) function (e.g. raised creatinine or urea).

Rare (may affect up to 1 in 1,000 people):

•    mood disorders

•    nightmares

•    abnormal blood count, including:

•    abnormal differential blood count

•    decreased number of white blood cells (leucocytopenia)

•    decreased number of blood platelets (thrombocytopenia)

These effects may lead to increased risk of infection and symptoms such as bruising or nosebleeds.

•    ringing in the ears (tinnitus)